Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | 394.37%4.04M | -142.69%-447K | -6.49%14.53M | 61.60%11.6M | -81.84%1.07M | -72.73%817K | 301.35%1.05M | 187.79%15.54M | 16.60%7.18M | 65.50%5.89M |
| Net profit before non-cash adjustment | 2.70%4.61M | 31.93%3.67M | 21.89%13.68M | 7.72%1.91M | 3.21%4.5M | 34.90%4.49M | 57.82%2.78M | 184.28%11.23M | 47.45%1.77M | 518.13%4.36M |
| Total adjustment of non-cash items | 43.36%767K | 40.63%713K | -10.14%1.73M | -70.54%164.02K | 41.19%521K | -3.08%535K | 14.19%507K | 24.50%1.92M | 174.82%556.82K | -6.82%369K |
| -Depreciation and amortization | 99.48%774K | 23.15%734K | 27.90%2.32M | 57.60%764.36K | 20.63%573K | -15.65%388K | 50.89%596K | 32.16%1.82M | 15.37%485K | 44.38%475K |
| -Reversal of impairment losses recognized in profit and loss | -66.67%50K | --75K | -224.72%-450.31K | -500.06%-600.31K | --0 | 100.00%150K | --0 | 417.70%361.06K | 115.16%150.06K | --61K |
| -Disposal profit | --0 | -163.16%-100K | 69.05%-38.83K | -261.12%-833 | --0 | --0 | ---38K | 49.61%-125.48K | 100.21%517 | ---129K |
| -Net exchange gains and losses | -118.18%-10K | --13K | 64.79%-188 | -67.07%812 | -5,500.00%-56K | 150.00%55K | --0 | 98.76%-534 | 106.67%2.47K | 83.33%-1K |
| -Other non-cash items | 18.97%-47K | 82.35%-9K | 18.10%-105.01K | 99.99%-10 | 110.81%4K | -625.00%-58K | -2,450.00%-51K | -132.67%-128.22K | -5,232.90%-81.22K | -150.68%-37K |
| Changes in working capital | 68.21%-1.34M | -115.37%-4.83M | -136.77%-879.6K | 96.44%9.53M | -442.81%-3.96M | -376.33%-4.21M | 17.74%-2.24M | 2,681.81%2.39M | 2.06%4.85M | -52.99%1.15M |
| -Change in receivables | 26.28%-1.69M | -730.21%-4.51M | 173.43%3.36M | 103.69%6.99M | 19.02%-2.05M | 10.82%-2.29M | 124.62%715K | -239.40%-4.58M | 825.61%3.43M | -278.20%-2.53M |
| -Change in inventory | 168.57%1.75M | 81.96%-1.02M | -143.17%-3.06M | 69.73%3.84M | -67.68%1.29M | -2,774.16%-2.56M | -714.85%-5.63M | 335.56%7.09M | -33.80%2.26M | 894.63%4M |
| -Change in payables | -318.04%-1.4M | -74.22%689K | -905.92%-1.18M | -54.28%-1.3M | -934.30%-3.2M | -63.77%643K | 461.22%2.67M | 68.02%-117.43K | -187.51%-843.43K | -120.12%-309K |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | ||||||||||
| Interest received (cash flow from operating activities) | ||||||||||
| Tax refund paid | 0.43%-458K | 10.63%-622K | -55.78%-2.99M | 42.32%-606.39K | -199.76%-1.23M | -68.50%-460K | -276.22%-696K | -27.42%-1.92M | -23,209.93%-1.05M | 10.50%-409K |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | 903.08%3.58M | -404.56%-1.07M | -15.27%11.54M | 79.44%10.99M | -102.87%-157K | -86.89%357K | 149.79%351K | 249.80%13.62M | -0.40%6.13M | 76.71%5.48M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | -10,608.00%-2.63M | 45.79%-1.47M | 8.46%-5.31M | 32.06%-3.02M | 6,916.67%409K | 103.45%25K | -339.26%-2.72M | -55.45%-5.8M | -80.22%-4.45M | 99.03%-6K |
| Net business purchase and sale | ---- | ---- | --0 | ---4K | ---- | ---- | ---- | --0 | --0 | ---- |
| Net investment product transactions | -58.33%1M | -742.86%-4.5M | 44.67%4M | -90.54%300K | 142.86%600K | 500.00%2.4M | 17.65%700K | 128.32%2.77M | 132.46%3.17M | ---1.4M |
| Advance cash and loans provided to other parties | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Interest received (cash flow from investment activities) | 2.67%77K | -65.75%25K | -40.64%251.88K | -60.39%44.88K | -37.23%59K | -28.57%75K | -34.82%73K | 72.42%424.31K | -28.32%113.31K | 38.24%94K |
| Investing cash flow | -162.00%-1.55M | -205.70%-5.95M | 59.54%-1.06M | -130.13%-2.68M | 181.71%1.07M | 1,241.55%2.5M | -2,311.36%-1.95M | 80.31%-2.61M | 90.35%-1.17M | -138.98%-1.31M |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | 70.91%-105K | -0.55%-363K | 42.97%-1.37M | 3.78%-337.59K | 4.88%-312K | -24.05%-361K | 74.84%-361K | 2.70%-2.4M | -141.99%-350.86K | 91.02%-328K |
| Net common stock issuance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Increase or decrease of lease financing | --0 | 97.18%-2K | 32.87%-265.44K | -2.46%-85.44K | 241.84%139K | -129.63%-248K | 33.02%-71K | -28.56%-395.38K | -193.21%-83.38K | -27.27%-98K |
| Issuance fees | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash dividends paid | --0 | ---2.8M | -27.27%-5.6M | --0 | ---- | ---- | ---- | ---4.4M | ---2.4M | --0 |
| Interest paid (cash flow from financing activities) | -114.29%-30K | 27.27%-16K | 48.59%-152.22K | -37.80%-44.22K | -26.32%-72K | 85.57%-14K | 80.00%-22K | 53.63%-296.09K | 79.50%-32.09K | 59.57%-57K |
| Net other fund-raising expenses | ---- | ---- | --4.04K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Financing cash flow | 110.91%68K | -600.66%-3.18M | 1.48%-7.39M | 83.84%-463.21K | -1,110.14%-5.85M | 75.04%-623K | 72.50%-454K | -143.86%-7.5M | -472.73%-2.87M | 87.52%-483K |
| Net cash flow | ||||||||||
| Beginning cash position | -39.05%7.88M | 20.71%18.08M | 30.69%14.98M | -20.58%10.23M | 64.82%15.16M | 40.65%12.93M | 30.69%14.98M | 208.06%11.46M | -22.47%12.88M | -48.71%9.2M |
| Current changes in cash | -6.04%2.1M | -397.76%-10.2M | -11.81%3.1M | 274.76%7.85M | -233.86%-4.93M | 27,825.00%2.23M | 9.66%-2.05M | -54.56%3.52M | 140.61%2.09M | 379.23%3.68M |
| End cash Position | -34.19%9.98M | -39.05%7.88M | 20.71%18.08M | 20.71%18.08M | -20.58%10.23M | 64.82%15.16M | 40.65%12.93M | 30.69%14.98M | 30.69%14.98M | -22.47%12.88M |
| Free cash flow | 381.31%953K | -9.85%-2.64M | -19.46%6.2M | 375.06%7.97M | -91.84%436K | -90.09%198K | -81.72%-2.41M | 9,220.38%7.69M | -51.14%1.68M | 115.18%5.34M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.